2022.Oct.03

Announcement of the expiration of AP Biosciences’ 2022 cash capital increase call period

1.Date of occurrence of the event:2022/10/03 2.Company name:AP Biosciences Inc. (hereinafter referred to as APBio) 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Subsidiaries 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence: APBio’s 2022 cash capital increase, with a call period of payment from 2022/09/01 to 2022/10/03 15:30, ends today. 6.Countermeasures: (1)Shareholders who haven’t paid […]

HOMEWhat’s NewAnnouncementsAnnouncement of the expiration of AP Biosciences’ 2022 cash capital increase call period

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2022.Sep.12

Announcement on behalf of AP Biosciences to file application for Phase I human clinical trial of Bispecific Antibody, AP203, to TFDA

2022.Oct.04

Announcement of AP Biosciences’ full receipt of cash capital increase in 2022 and the reference date of capital increase